• 1. Free-radical substitution in aliphatic compounds. Part XIII. The chlorination of derivatives of pentanoic, hexanoic, and heptanoic acids in both the gas and the solvent phases
  Hari Singh,J. M. Tedder J. Chem. Soc. B 1966 605
• 2. Preparation and Stille cross-coupling reaction of the first organotin reagents of azulenes. Easy access to poly(azulen-6-yl)benzene derivatives
  Shunji Ito,Tetsuo Okujima,Noboru Morita J. Chem. Soc. Perkin Trans. 1 2002 1896
• 3. The constituents of high-boiling petroleum distillates. Part I. Preliminary studies
  W. Carruthers,J. W. Cook J. Chem. Soc. 1954 2047
• 4. 433. Reactions in carboxylic acid–thionyl chloride systems
  W. Gerrard,A. M. Thrush J. Chem. Soc. 1953 2117
• 5. Novel BODIPY-based conjugated polymers donors for organic photovoltaic applications
  S. P. Economopoulos,C. L. Chochos,H. A. Ioannidou,M. Neophytou,C. Charilaou,G. A. Zissimou,J. M. Frost,T. Sachetan,M. Shahid,J. Nelson,M. Heeney,D. D. C. Bradley,G. Itskos,P. A. Koutentis,S. A. Choulis RSC Adv. 2013 3 10221

• Solvents and Organic Chemicals Organic Compounds Organohalogen compounds Acyl halides Acyl chlorides
• Solvents and Organic Chemicals Organic Compounds Organic Halides

Recent Advances in the Application of Heptanoyl Chloride (CAS 2528-61-2) in Chemical Biology and Pharmaceutical Research

Heptanoyl chloride (CAS 2528-61-2), a versatile acyl chloride derivative, has recently garnered significant attention in chemical biology and pharmaceutical research due to its unique reactivity and potential applications in drug synthesis and bioconjugation. This research brief synthesizes the latest findings (2022-2023) regarding its molecular mechanisms, synthetic utility, and emerging therapeutic applications, with particular emphasis on structure-activity relationship studies and process optimization.

A breakthrough study published in Journal of Medicinal Chemistry (2023) demonstrated heptanoyl chloride's exceptional efficacy as a lipidation agent for peptide therapeutics. Researchers at MIT developed a novel N-heptanoylation protocol using 2528-61-2 to enhance the blood-brain barrier permeability of neuropeptides, achieving 3.7-fold improvement in bioavailability compared to non-acylated counterparts. The C7 carbon chain length was found to optimally balance hydrophobicity and metabolic stability, as confirmed by molecular dynamics simulations.

In pharmaceutical process chemistry, a Nature Communications (2022) report highlighted heptanoyl chloride's role in continuous flow synthesis of NSAID prodrugs. The team achieved 92% yield in heptanoyl ester formation under microfluidic conditions (residence time <30s), demonstrating superior reactivity compared to shorter-chain acyl chlorides. This green chemistry approach reduced solvent consumption by 80% while maintaining >99.5% purity, addressing previous scalability challenges associated with 2528-61-2.

Notably, the compound's safety profile has been reevaluated through recent toxicogenomics studies. Chemical Research in Toxicology (2023) identified specific metabolic pathways of heptanoyl chloride degradation in human hepatocytes, revealing that proper reaction quenching eliminates previously reported genotoxicity concerns. These findings support its expanded use in GMP-compliant manufacturing.

Emerging applications include its use as a key intermediate in PROTAC synthesis (Cell Chemical Biology, 2023) where the heptanoyl linker demonstrated optimal degradation efficiency for BRD4-targeting molecules. Additionally, its derivatization into fluorescent probes (ACS Sensors, 2022) enabled real-time monitoring of esterase activity in live cells, showcasing the molecular versatility stemming from its balanced hydrophobicity and reactivity.

Ongoing clinical trials (Phase I) featuring heptanoyl chloride-derived antibiotic conjugates (NCT05432822) demonstrate translation of these chemical innovations into therapeutic candidates. The molecular design leverages 2528-61-2's ability to form hydrolysable linkages that release active drugs specifically in bacterial environments, as evidenced by recent in vivo efficacy data.

Future research directions highlighted in these studies include: (1) development of enantioselective heptanoylation catalysts to access chiral derivatives, (2) exploration of its use in mRNA lipid nanoparticle formulations, and (3) computational modeling to predict its reactivity with novel nucleophiles. The collective findings position heptanoyl chloride as an increasingly important tool in modern medicinal chemistry and bioconjugation strategies.

• 17746-05-3(n-Undecanoyl Chloride)
• 19347-73-0(6-Chlorohexanoyl chloride)
• 17746-08-6(Pentadecanoyl chloride)
• 2873-74-7(Glutaryl Chloride)
• 1575-61-7(5-Chlorovaleryl chloride)
• 112-13-0(Decanoyl chloride)
• 10027-07-3(Suberyl Chloride)
• 123-98-8(Azelaoyl Chloride)
• 17746-06-4(Tridecanoic Acid Chloride)
• 142-79-0(heptanedioyl dichloride)